$55.70+0.58 (+1.05%)
H.B.
H.B. Fuller Company in the Basic Materials sector is trading at $55.70 with a market capitalization of $3.1B. Wall Street consensus targets $73.29 (7 analysts), implying a +31.6% move over the next 12 months. The stock is currently 19% below its 52-week high of $68.63, remaining 7.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $950.27Mβ | $770.84Mβ | $894.79Mβ | $892.04Mβ | $898.10M |
| Gross Profit | $319.65Mβ | $236.05Mβ | $282.08Mβ | $285.11Mβ | $286.38M |
| Operating Income | $117.29Mβ | $51.60Mβ | $121.25Mβ | $110.14Mβ | $100.04M |
| Net Income | $67.81Mβ | $21.05Mβ | $29.73Mβ | $67.16Mβ | $41.83M |
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, He...
H. B. Fuller (FUL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FUL vs. NVZMY: Which Stock Is the Better Value Option?
CLDT, PARR, ARCO, CAL and FUL stand out with attractive EV-to-EBITDA ratios and strong earnings outlook.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still clouds its path to stronger growth.